Turakhia Minang 4
4 · iRhythm Holdings, Inc. · Filed Feb 26, 2026
Research Summary
AI-generated summary of this filing
iRhythm (IRTC) Chief Med/Sci Officer Minang Sells Shares
What Happened
- Turakhia Minang, Chief Medical/Sci Officer and EVP Advanced Technology at iRhythm Holdings (IRTC), had 15,060 performance RSUs vest on Feb 24, 2026 (acquired at $0.00 per share) and sold 7,804 shares on Feb 25, 2026 in an open-market/related sale at $135.42 per share, generating proceeds of $1,056,809. The sale was reported on a Form 4 filed Feb 26, 2026.
Key Details
- Transaction dates and prices:
- 2026-02-24: Award/acquisition of 15,060 shares (performance RSUs vested) @ $0.00 (Footnote F1).
- 2026-02-25: Sale of 7,804 shares @ $135.42 = $1,056,809 (Footnote F2).
- Purpose of sale: Footnote F2 states the shares were sold to cover tax withholding and remittance obligations related to the RSU vesting.
- Shares owned after the transactions: Not specified in the Form 4 filing.
- Filing: Form 4 filed 2026-02-26 (covers 2/24–2/25 transactions); no indication in the filing that it was late.
- Corporate note: On Jan 12, 2026 iRhythm Tech completed a holding company reorganization; all prior shares/equity converted one-for-one to iRhythm Holdings securities (see Remarks).
Context
- This filing documents RSU vesting and a related sale to cover taxes — a common, routine action following equity award vesting. The filing is informational; it does not state any change in ongoing ownership beyond the amounts reported.
Insider Transaction Report
Form 4
Turakhia Minang
CHIEF MED/SCI OFCR EVP ADVTECH
Transactions
- Award
Common Stock
[F1]2026-02-24+15,060→ 56,703 total - Sale
Common Stock
[F2]2026-02-25$135.42/sh−7,804$1,056,809→ 48,899 total
Footnotes (2)
- [F1]Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on February 27, 2023.
- [F2]These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.
Signature
/s/ Marc Rosenbaum, attorney-in-fact|2026-02-26